Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabeloop Algorithm in Type 1 Diabetes (WP6-1)
NCT02101229Phase 3Completed
- Sponsor
- CERITD
- Start
- May 2014
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), sponsored by CERITD. Started May 2014; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02101229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101229.